InvestorsHub Logo
Followers 81
Posts 24739
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 03/15/2024 9:17:34 AM

Friday, March 15, 2024 9:17:34 AM

Post# of 27669
GLMD - .349 Pre-market at .4655/.4656

Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.